Literature DB >> 6221624

Gastric cytoprotection by agents altering gastric mucosal sulfhydryl compounds: role of endogenous prostaglandins.

S J Konturek, T Brzozowski, I Piastucki, T Radecki, S Szabo.   

Abstract

Intragastric administration of cysteamine or diethyl maleate caused a dose-dependent reduction in the mean area of gastric lesions induced by absolute ethanol but failed to affect gastric ulcerations produced by acidified aspirin. Mucosal levels of glutathione were increased with cysteamine and reduced with diethyl maleate and did not correlate with the protective action of these agents on ethanol-induced mucosal lesions. The protective effects of these agents probably involved mucosal generation of prostaglandins, because pretreatment with indomethacin or aspirin, potent inhibitors of cyclooxygenase, partially prevented this protection. This study indicates that the mucosal generation of prostaglandins contributed, at least in part, to the gastric cytoprotection by agents altering mucosal contents of sulfhydryl compounds.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221624

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Leukot Res        ISSN: 0732-8141


  3 in total

Review 1.  Stress-induced vascular damage and ulcer.

Authors:  T Yabana; A Yachi
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

2.  Glutathione and N-acetylcysteine reduce gastric mucosal blood flow in rats.

Authors:  K K Ovrebø; H Sørbye; A Svardal; K Grong; K Svanes
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

3.  Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.

Authors:  Predrag Sikiric; Anita Skrtic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Eva Lovric; Suncana Sikiric; Mario Knezevic; Sanja Strbe; Marija Milavic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.